In the United States, approximately 12,000 patients present with glioblastoma, a very aggressive brain or spinal cord cancer, each year. Glioblastoma has no cure and a median survival period of 15-18 months. Gliomas are very difficult to remove entirely with surgery because of their highly invasive growth and require a second line of attack.
As another touchpoint in a lasting relationship between the University of Minnesota College of Veterinary Medicine (CVM) and the Grand Portage Band of Lake Superior Ojibwe, a team of CVM researchers led by Tiffany Wolf, DVM, PhD, recently received more than $70,000 from project led by Seth Moore, PhD, director of biology and environment at the Grand Portage Band, to continue assisting the tribal nation in investigating moose habitat and population health in a changing climate.
A live recombinant Pichinde virus (PICV) vector vaccine is safe and effective against turkey arthritis reovirus (TARV), according to a recent study led by Sunil Mor, BVSc & AH, MVSc, PhD, and Hinh Ly, PhD. Vaccination may be an effective way to reduce lameness induced by TARV in flocks, but there are currently no commercial TARV vaccines available.
Mild gastrointestinal erosions are more common in dogs treated with anti-inflammatory medications (NSAIDs) over a long period of time than in control dogs with chronic gastrointestinal (GI) disease, according to a recent study led by Tracy Hill, DVM, DACVIM, PhD, DECVIM. NSAIDs are the pharmaceutical most associated with gastroduodenal ulceration and perforation in dogs. However, the prevalence of GI injury associated with chronic use of NSAIDs in dogs is unknown.
Building on previous success, University of Minnesota researchers Maxim Cheeran, BVSC, MVSc, PhD, and